SCHEMBL94839

SCHEMBL94839

[CH2]c1ccc(C(=O)N(CC)Cc2c(C)cccc2C)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
OPRM1 P35372 2/20 0.47
OPRD1 P41143 2/20 0.47
OPRK1 P41145 2/20 0.47
HPGD P15428 6/20 0.46
ALDH1A1 P00352 2/20 0.46
MAPT P10636 1/20 0.46
LPAR1 Q92633 2/20 0.46
LPAR5 Q9H1C0 2/20 0.46
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TDP1 Q9NUW8 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.42
MLYCD O95822 1/20 0.42
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5543735 0.81 HPGD (0.61) HPGDALDH1A1MAPTMEN1LMNA
SCHEMBL94864 0.76 PPARG (0.49) TSHRMAPK1HPGDALDH1A1MAPT
SCHEMBL2960979 0.75 USP2 (0.58) TSHRMAPK1HPGDALDH1A1MAPT
SCHEMBL95412 0.75 HDAC1 (0.52) OPRM1OPRD1OPRK1HPGDALDH1A1
SCHEMBL96528 0.72 LPAR1 (0.54) OPRM1OPRD1HPGDALDH1A1MAPT
SCHEMBL94674 0.71 ALDH1A1 (0.68) ALDH1A1MAPTLPAR1LPAR5LMNA
SCHEMBL95772 0.71 HDAC1 (0.52) LPAR1LPAR5MEN1KMT2AHDAC1
SCHEMBL5703500 0.71 HPGD (0.73) HPGDALDH1A1MAPTMEN1LMNA
SCHEMBL25138742 0.71 HDAC1 (0.71) TSHRMAPK1OPRD1HPGDALDH1A1
SCHEMBL5543209 0.71 MLYCD (0.62) TSHROPRD1HPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
EP-2043644-A1 NF- B INHIBITOR Otsuka Pharmaceutical Co., Ltd. (JP) 2009-04-08 EP disclosed
WO-2008010601-A1 NF- ϰB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-01-24 WO disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB TSHR 3439/4885MAPK1 173/4885OPRM1 3508/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 TSHR 110/4885MAPK1 982/4885OPRM1 3375/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 TSHR 110/4885MAPK1 982/4885OPRM1 3375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.